ADGC Publications

Found 248 results
2011
Naj AC, Jun G, Beecham GW, Wang L-S, Vardarajan BNarayan, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK et al..  2011.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.. Nat Genet. 43(5):436-41.
Jayadev S, Nochlin D, Poorkaj P, Steinbart EJ, Mastrianni JA, Montine TJ, Ghetti B, Schellenberg GD, Bird TD, Leverenz JB.  2011.  Familial prion disease with Alzheimer disease-like tau pathology and clinical phenotype.. Ann Neurol. 69(4):712-20.
Chen-Plotkin AS, Martinez-Lage M, Sleiman PMA, Hu W, Greene R, Wood EMcCarty, Bing S, Grossman M, Schellenberg GD, Hatanpaa KJ et al..  2011.  Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration.. Arch Neurol. 68(4):488-97.
Hamilton KL, Naj AC, Park YS, Gallins PJ, Rajbhandary RA, Beecham GW, Martin ER, Haines JL, Pericak-Vance MA.  2011.  Genome-wide Association Analyses Identifies Novel Loci Associated with the Onset Age Among Cases with Late-Onset Alzheimer’s Disease. ASHG/ICHG 2011 (Montreal, Canada).
Kauwe JSK, Cruchaga C, McKean D, Bailey M, Patty D, Mayo K, Bertlesen S, Hinrichs A, Fagan A, Holtzman D et al..  2011.  Genome-wide association analyses using cerebrospinal fluid Aβ42 levels as endophenotype for Alzheimer’s disease. ASHG/ICHG 2011 (Montreal, Canada).
Cruchaga C, Kauwe JSK, McKean D, Bailey M, Patty D, Mayo K, Bertlesen S, Hinrichs A, Peskind E, Li G et al..  2011.  Genome-wide association analyses using cerebrospinal fluid tau and phospho-tau and Aβ42 levels as endophenotypes for Alzheimer’s disease. AAIC (ICAD) 2011, Paris, France.
Jun G, Buros J, Vardarajan BNarayan, Lunetta KL, Farrer LA.  2011.  Genome-wide scan suggested novel Alzheimer disease susceptibility genes by factoring influence of APOE. ASHG/ICHG 2011 (Montreal, Canada).
Höglinger GU, Melhem NM, Dickson DW, Sleiman PMA, San Wang L-, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE et al..  2011.  Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.. Nat Genet. 43(7):699-705.
Sherva R, Farrer LA.  2011.  Power and pitfalls of the genome-wide association study approach to identify genes for Alzheimer's disease.. Curr Psychiatry Rep. 13(2):138-46.
2010
Li G, Shofer JB, Rhew IC, Kukull WA, Peskind ER, McCormick W, Bowen JD, Schellenberg GD, Crane PK, Breitner JCS et al..  2010.  Age-varying association between statin use and incident Alzheimer's disease.. J Am Geriatr Soc. 58(7):1311-7.
Koelle DM, Magaret A, Warren T, Schellenberg GD, Wald A.  2010.  APOE genotype is associated with oral herpetic lesions but not genital or oral herpes simplex virus shedding.. Sex Transm Infect. 86(3):202-6.
Bekris LM, Galloway NM, Montine TJ, Schellenberg GD, Yu C-E.  2010.  APOE mRNA and protein expression in postmortem brain are modulated by an extended haplotype structure.. Am J Med Genet B Neuropsychiatr Genet. 153B(2):409-417.
Van Deerlin VM, Sleiman PMA, Martinez-Lage M, Chen-Plotkin A, San Wang L-, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Grossman M et al..  2010.  Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions.. Nat Genet. 42(3):234-9.
Kay DM, Stevens CF, Hamza TH, Montimurro JS, Zabetian CP, Factor SA, Samii A, Griffith A, Roberts JW, Molho ES et al..  2010.  A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2.. Neurology. 75(13):1189-94.
Borenstein AR, Mortimer JA, Schellenberg GD, DeCarli C, Copenhaver C, Galasko D, Salmon DP, Petersen R.  2010.  Effects of apolipoprotein E-epsilon4 and -epsilon2 in amnestic mild cognitive impairment and dementia in Shanghai: SCOBHI-P.. Am J Alzheimers Dis Other Demen. 25(3):233-8.
Marchani EE, Bird TD, Steinbart EJ, Rosenthal E, Yu C-E, Schellenberg GD, Wijsman EM.  2010.  Evidence for three loci modifying age-at-onset of Alzheimer's disease in early-onset PSEN2 families.. Am J Med Genet B Neuropsychiatr Genet. 153B(5):1031-41.
Han M-R, Schellenberg GD, San Wang L-.  2010.  Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.. BMC Neurol. 10:90.
Melrose HL, Dächsel JC, Behrouz B, Lincoln SJ, Yue M, Hinkle KM, Kent CB, Korvatska E, Taylor JP, Witten L et al..  2010.  Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice.. Neurobiol Dis. 40(3):503-17.
Kraemer BC, Schuck T, Wheeler JM, Robinson LC, Trojanowski JQ, M Y Lee V, Schellenberg GD.  2010.  Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis.. Acta Neuropathol. 119(4):409-19.
Jun G, Naj AC, Beecham GW, Wang L-S, Buros J, Gallins PJ, Buxbaum JD, Ertekin-Taner N, M Fallin D, Friedland R et al..  2010.  Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes.. Arch Neurol. 67(12):1473-84.
Shen L, Qi Y, Kim S, Nho K, Wan J, Risacher SL, Saykin AJ.  2010.  Sparse bayesian learning for identifying imaging biomarkers in AD prediction.. Med Image Comput Comput Assist Interv. 13(Pt 3):611-8.
VanFossen BT, G Watson S, Baker LD, Rhoads KW, Cholerton BA, Reger MA, Plymate SR, Schellenberg G, Craft S.  2010.  Statin users without an APOE-epsilon4 allele have increased insulin resistance.. J Alzheimers Dis. 19(4):1149-53.
0
Mezlini AM, Magdamo C, Merrill E, Chibnik LB, Blacker DL, Hyman BT, Das S.  0.  Characterizing Clinical and Neuropathological Traits of APOE Haplotypes in African Americans and Europeans.. J Alzheimers Dis. 78(1):467-477.

Pages